Latest Breaking News On - Sai sankar - Page 1 : comparemela.com

Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions News provided by Share this article Share this article NEW YORK, May 4, 2021 /PRNewswire/ U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for direct application system and method for the delivery of bioactive compositions and formulations. The invention utilizes a repeated motion delivery technology (AQT Technology), creating a new route of administration (RoA) and mode of administration (MoA) for the pharmaceutical and biotechnology industry for the first time in decades. “This patent combined with our recent acquisition of a License for a new botulinum toxin asset will ignite many advancements in the industry and provide limitless opportunities for New Drug Applications (NDA) or Biologics License Applications (BLA).” says Sobin Chang, MPH., CEO of Aquavit.

Sobin changDavid shaferAquavit pharmaceuticals incTechnology officerNew drug applicationsBiologics license applicationsChief medical technologySai sankarChief biomedicalAquavit pharmaceuticalsடேவிட் ஷாபெர்தொழில்நுட்பம் அதிகாரிபுதியது மருந்து பயன்பாடுகள்உயிரியல் உரிமம் பயன்பாடுகள்சாய் சங்கர்தலைமை உயிர் மருத்துவ